Chemical Information:
- Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆ (approx.)
- Molecular Weight: ~3647.2 Da
- Class: GHRH analogue peptide
Description:
CJC-1295 (No DAC) combined with Ipamorelin is a dual-peptide research blend designed to investigate synergistic stimulation of growth hormone release through complementary mechanisms. CJC-1295 (No DAC) acts as a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin functions as a selective ghrelin receptor agonist (GHRP). Together, they are studied in laboratory models for their effects on pulsatile GH secretion, endocrine signaling amplification, and downstream IGF-1 modulation under controlled experimental conditions.
Research Applications:
- Synergistic GH Secretion Studies: Used to investigate combined activation of GHRH and ghrelin receptor pathways for enhanced GH pulse modeling.
- Endocrine Axis Interaction Research: Examines hypothalamic–pituitary signaling coordination and hormonal feedback regulation.
- IGF-1 Pathway Studies: Used in research on downstream IGF-1 production and anabolic signaling cascades.
- Metabolic and Recovery Pathway Modeling: Investigates protein synthesis, metabolic regulation, and cellular recovery responses in experimental systems.
Storage and Handling:
- Store at -20°C (long-term)
- Refrigerate at 2–8°C after reconstitution
- Avoid repeated freeze-thaw cycles
- Protect from light and moisture
Product Specifications:
- Appearance: White to off-white powder
- Purity: ≥98% (HPLC)
- Solubility: Water-soluble
Compliance Notice:
This product is intended strictly for laboratory research use only. It is not approved for human or veterinary use and is not intended for diagnosis, treatment, or therapeutic applications. Not evaluated by regulatory authorities such as the FDA. Handle only in controlled laboratory environments by qualified personnel.
Reviews
There are no reviews yet.